Biotech Showcase
Save the date!
Biotech Showcase 2023January 9–11, 2023

Berra Yazar-Klosinski
CSO at Multidisciplinary Association for Psychedelic Studies (MAPS)

Profile

BERRA YAZAR-KLOSINSKI, PhD, is the Chief Scientific Officer of MAPS Public Benefit Corporation and Deputy Director of the 501(c)(3) non-profit, MAPS. Dr. Yazar-Klosinski is responsible for development of strategic, catalytic, and capacity-building activities to facilitate research on psychedelics in compliance with the global regulatory landscape. She has been actively involved in the clinical development of MDMA-assisted therapy, LSD-assisted therapy, cannabis, and ibogaine. After gaining experience in clinical research laboratories with Geron Corporation and Millennium Pharmaceuticals, Dr. Yazar-Klosinski joined MAPS in 2009 to work with an organization where profit wouldn't dictate the agenda of scientific research. She has supported MAPS clinical research and regulatory affairs through all stages of growth for over a decade. Dr. Yazar-Klosinski earned her B.S. in Biology with a minor in Drama from Stanford University and her Ph.D. in Molecular, Cell, and Developmental Biology from University of California, Santa Cruz.

Agenda Sessions

  • Psychedelics: Once Stigmatized, Are Now the Newest Therapeutics on the Block for Mental Health

    08:00

Speakers at this event